The landscape of abortion access in the United States has been dramatically impacted by legislative changes following the Supreme Court’s reversal of Roe v. Wade in 2022. Despite efforts by anti-abortion advocates to restrict abortion access through various laws and court cases, recent data suggest that the overall number of abortions has remained stable.
Stability in Abortion Rates
A report from the Guttmacher Institute reveals that approximately 1.1 million abortions were performed in the United States in both 2024 and 2025. “There were an estimated 1,126,000 abortions provided by clinicians in the U.S. in 2025 — that’s pretty much unchanged from 2024,” noted Isaac Maddow-Zimet, a data scientist at the Guttmacher Institute, which is recognized for its research supporting abortion access.
This consistent figure comes as many states have enacted stricter regulations aimed at making access to abortion more difficult. Advocates seeking to limit abortion rights have pursued various legislative actions, but the data indicate minimal change in the number of abortions performed.
Telemedicine as a Key Factor
Telemedicine has emerged as a significant mechanism for maintaining access to abortion services, especially in states with stringent abortion laws. In 2023, the Food and Drug Administration (FDA) permitted prescriptions for mifepristone, one of the two medications used in medical abortions, to be issued without an in-person consultation. This change has permitted many women to access medications without the need to travel to clinics, which is particularly beneficial for those living in states where access is severely restricted.
Alongside this, several states with protective abortion laws have established “shield laws.” These laws protect healthcare providers from legal risks when they prescribe abortion medications to patients located in states with bans. As a result, the reliance on telemedicine for abortion services has increased, while the need for individuals to travel across state lines has diminished.
According to the Guttmacher report, this evolution indicates that fewer people sought abortions by traveling, as a significant number were able to access care through telehealth platforms. “It makes sense that we’d see a decline in travel because people accessing abortion care through telehealth in general then no longer need to travel for care,” Maddow-Zimet explained.
Personal Experiences: The Role of Medication by Mail
Individuals seeking abortions have found alternative pathways amid restrictive legislation. For instance, a woman known only as Viv, a 27-year-old resident of Atlanta, discovered she was pregnant just after Georgia’s six-week abortion ban. Rather than traveling for care, Viv sought abortion pills online. “I didn’t want to travel. I didn’t want to take time off of work. I am pretty knowledgeable about women’s health, and I know that the abortion pill is a safe and effective way to have an abortion,” she stated.
Viv utilized a service that allowed her to receive the medications at home, highlighting how modern methods of telehealth and mail deliveries are reshaping the landscape of abortion access. She noted that support continued even after the pills were received, with follow-up communications ensuring her well-being following the procedure.
Ongoing Legal and Regulatory Challenges
Despite the effective use of telemedicine, opponents of abortion rights continue to push for stricter regulations and legal challenges to the availability of abortion medications. Legislative actions, including bills aimed at prohibiting the mail distribution of mifepristone, have been introduced at various levels of government. Notably, Louisiana Attorney General Liz Murrill has initiated legal actions challenging the FDA’s regulations, arguing that the federal rules must change to enhance state efforts to regulate abortion medication more effectively.
The Guttmacher report indicates that while about 2,500 abortions were performed in Louisiana in 2023, there were over 9,000 in the previous year. The data suggest that many individuals in states with bans have turned to telehealth for abortions, with around 91,000 patients reportedly having received telehealth abortions in states with restrictive laws.
The outcome of ongoing litigation, including the anticipated ruling in Louisiana v. FDA, will be pivotal in shaping future regulations concerning abortion access and medication use.
Conclusion
As the legal, medical, and personal landscape surrounding abortion continues to evolve, the steady rate of abortions in the U.S. highlights resilient methods of care. The increasing reliance on telemedicine and medication access reflects broader changes within the healthcare system, even amid pervasive legal and regulatory challenges. The situation calls for continuous monitoring as lawmakers and advocates on both sides of the abortion debate navigate this complex environment.
Source reference: Full report
About The Author
